Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AXIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SORBS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LATS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101927877 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SETDB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUTM2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G6PD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF592 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKBKG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOCOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on